This technology might solve the problem gene therapy because so far DPC technology can attach targeting molecules eventually attach to target cells of interest, and attach interaction-inhibiting agents to the polymer to prevent unwanted interactions with non-target cells
# Pathway IV™
This novel, clinically practical procedure might be the answer for the gene therapy as it is a simple, elegant method which has several special features such as overcome the delivery hurdle that lead to ease of repeat administration. It is able to target large numbers of cells within multiple muscle groups enables unprecedented levels of expression, and single dose can result in long term gene expression. All these features are keys to clinical utility for chronic diseases. By using this technology to answer problem in gene therapy, muscle will be the candidate of host site for gene therapies that induce secretion of therapeutic proteins to treat a range of diseases, including anemia, arthritis, ALS, and cancer immunotherapeutic.
